Medical Weight Loss for Leavenworth, Kansas Residents

Leavenworth, Kansas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Leavenworth through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Leavenworth? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in Kansas. Doctor review just $119 (medication separate).

Why Leavenworth Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Leavenworth is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Kansas trust us to guide a serious decision about their health.

From our Costa Mesa, California practice, we provide Leavenworth with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Telehealth is what lets us care for Leavenworth, Kansas from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout downtown Leavenworth and the greater Leavenworth County area of the Kansas City metro. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Leavenworth, even on warm Kansas afternoons.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Leavenworth or a rural corner of Kansas. Getting started in Leavenworth is simple: a Kansas licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Across both the urban and rural stretches of Kansas, New Hope Weight Loss cares for patients entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Leavenworth meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Leavenworth

Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.

Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.

Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Leavenworth address in cold-pack packaging.

Step 4: Follow-ups. You stay in touch by video as you progress.

Frequently Asked Questions, Leavenworth

Does New Hope Weight Loss actually serve Leavenworth, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Leavenworth, Kansas through telehealth. Residents across neighborhoods like downtown Leavenworth and the greater Leavenworth County area of the Kansas City metro qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Leavenworth?

Yes, it is fully remote. There is no in-person requirement for Leavenworth patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Leavenworth patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Leavenworth residents pay no added distance fee.

What areas of Leavenworth do you serve?

We serve patients from across Leavenworth by telehealth, including downtown Leavenworth and the greater Leavenworth County area of the Kansas City metro.

How does telehealth treatment work for Leavenworth patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Leavenworth address. Follow-ups also happen by video.

Leavenworth Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Leavenworth, Kansas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.